Definitive Contract 75N91023C00002
Award Date 2/1/23
Potential Completion Date 1/31/28
Potential Value $38M
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Frederick, MD 21703, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract awarded by the National Cancer Institute (NCI), a civilian agency, to Fisher Bioservices Inc. Clinical Trials Division, a subsidiary of Thermo Electron Corporation. The $81,331,761.57 definitive, cost-plus-fixed-fee contract is for the storage and distribution of chemicals and drugs used in preclinical evaluation and development. The contract has an ultimate completion date of February 29, 2008 and was awarded on August 1, 2002 without a set-aside designation. The...
- This is a $11,167,035.62 Cost Plus Fixed Fee delivery order contract awarded by the National Cancer Institute (NCI) to Fisher Bioservices Inc., a subsidiary of Thermo Electron Corporation. The contract is for the registration, storage, and distribution of chemicals and drugs to support pre-clinical discovery, evaluation, and development. It is part of a larger $19 million single-award Indefinite Delivery Vehicle (IDV) contract between NCI and Fisher Bioservices for these services. The contract...
- This is a delivery order contract awarded by the National Cancer Institute (NCI) to Fisher Bioservices Inc., a subsidiary of Thermo Electron Corporation. The contract is for a base period of 1 year, from April 1, 2023 to March 31, 2024, with a total potential value of $1,794,060.40 over the 5-year ordering period ending on March 31, 2028. The contract is for professional repository services, including the storage, maintenance, and distribution of chemicals, drugs, and other materials to...
- This is a federal contract award from the National Cancer Institute (NCI), a civilian agency, to Fisher Bioservices Inc.'s Clinical Trials Division, a subsidiary of Thermo Electron Corporation. The contract is for the registration, storage, and distribution of chemicals and drugs for pre-clinical discovery evaluation and development, with a ceiling value of $78,987.04. The contract is a delivery order under a larger indefinite delivery vehicle (IDV) contract valued at $19 million, which involves...
- This federal contract award to Fisher Bioservices Inc., a subsidiary of Thermo Electron Corporation, is valued at $11,793,466.15. The contract is for the web-based acquisition, receipt, storage, inventory, distribution, documentation, and control of synthetic compounds, purified natural products, and bulk drugs to support the National Cancer Institute's chemotherapeutic agent evaluation program. The contract is a Cost Plus Fixed Fee Definitive Contract without a set-aside designation. It...
- This is a definitive contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Fisher Bioservices Inc., a division of Thermo Electron Corporation, for the storage and distribution of clinical agents. The contract has a potential value of $29,398,963.86 and is a cost plus fixed fee arrangement. The contract does not have a set-aside designation. As a prime contractor, Fisher Bioservices provides a variety of goods and services to...
- This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to Fisher Bioservices Inc., a subsidiary of Thermo Electron Corporation. The $117,869.61 task order is for the registration, storage, and distribution of chemicals and drugs to support pre-clinical discovery, evaluation, and development. This is part of a larger single-award $19 million indefinite delivery contract between Fisher Bioservices and NCI for operating and maintaining the NCI's Chemotherapeutic...
- The National Institutes of Health National Cancer Institute awarded a $5.3 million delivery order contract to Fisher Bioservices Clinical Trials Division for the registration, storage, and distribution of chemicals and drugs in support of pre-clinical discovery, evaluation, and development efforts. Under the cost-plus-fixed-fee contract running from March 2021 through February 2023, Fisher Bioservices will provide services for the handling and management of chemicals and compounds as the NIH...
- This is a delivery order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Fisher Bioservices Inc. for the storage and management of monoclonal antibodies and interleukin-15 for use in clinical trials. The $1,083.30 firm-fixed-price contract is for option period 3 of the original agreement, with a period of performance ending on May 31, 2017. Fisher Bioservices is a subsidiary of Thermo Electron Corporation and has extensive experience...
- This federal contract award, valued at $149,777.24, was made by the National Cancer Institute (NCI) to Fisher Bioservices Inc., a subsidiary of Thermo Electron Corporation. The contract is for off-site storage of refrigerated, cryopreserved, and frozen biological materials. This delivery order contract is part of the Scientific Equipment and Services (FSS-66) schedule under the General Services Administration (GSA). The contract does not have a set-aside designation. Fisher Bioservices is an...